Fadox-CV Tablet is a combination antibiotic containing Cefpodoxime Proxetil 200mg and Clavulanic Acid 125mg, designed to treat a wide range of bacterial infections. Cefpodoxime Proxetil, a third-generation cephalosporin, works by inhibiting bacterial cell wall synthesis, leading to the destruction of susceptible bacteria. Clavulanic Acid, a beta-lactamase inhibitor, enhances the efficacy of Cefpodoxime by preventing bacterial enzymes from breaking down the antibiotic, thereby overcoming resistance in beta-lactamase producing bacteria. This synergistic combination is effective against respiratory tract infections, urinary tract infections, skin and soft tissue infections, and otitis media caused by both gram-positive and gram-negative bacteria. Fadox-CV is typically prescribed when infections are resistant to standard antibiotics or when a broad-spectrum antibiotic is required. It is important to take the medication exactly as prescribed by a healthcare professional and complete the full course to prevent the development of resistance. Common side effects may include gastrointestinal disturbances such as diarrhea, nausea, and abdominal pain. Patients with a history of penicillin or cephalosporin allergy should use this medication cautiously. Fadox-CV Tablet offers a potent and reliable option for managing bacterial infections effectively.